MaxCyte (MXCT) Insider Trading & Ownership $3.45 -0.04 (-1.15%) (As of 10:58 AM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends MaxCyte (NASDAQ:MXCT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.00%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$489,113.29Number OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$770,069.90 Get MXCT Insider Trade Alerts Want to know when executives and insiders are buying or selling MaxCyte stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address MXCT Insider Buying and Selling by Quarter Ad Colonial MetalsTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…Claim your FREE 2024 Gold Guide MaxCyte Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/28/2024John Joseph JohnstonDirectorSell3,000$3.72$11,160.00 10/2/2024Stanley C ErckDirectorSell21,607$3.71$80,161.97 9/26/2024John Joseph JohnstonDirectorSell3,000$3.82$11,460.00 9/4/2024Stanley C ErckDirectorSell29,767$3.97$118,174.99 8/26/2024John Joseph JohnstonDirectorSell3,000$4.28$12,840.00 8/1/2024Thomas M RossEVPSell15,476$4.54$70,261.04 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 7/26/2024John Joseph JohnstonDirectorSell3,000$4.75$14,250.00 7/9/2024Thomas M RossEVPSell13,531$4.03$54,529.93 6/27/2024John Joseph JohnstonDirectorSell10,000$3.99$39,900.00 6/20/2024Thomas M RossEVPSell33,333$4.09$136,331.97 6/10/2024Maher MasoudCEOBuy70,443$4.90$345,170.70 6/7/2024Maher MasoudCEOBuy29,557$4.87$143,942.59 3/26/2024John Joseph JohnstonDirectorSell5,000$4.41$22,050.00 1/26/2024John Joseph JohnstonDirectorSell5,000$5.12$25,600.00 12/26/2023John Joseph JohnstonDirectorSell5,000$4.53$22,650.00 12/1/2023Douglas DoerflerCEOSell20,200$5.00$101,000.00 11/29/2023Douglas DoerflerCEOSell5,350$5.00$26,750.00 11/27/2023John Joseph JohnstonDirectorSell5,000$4.59$22,950.00 (Data available from 1/1/2013 forward) MXCT Insider Trading Activity - Frequently Asked Questions Who is on MaxCyte's Insider Roster? The list of insiders at MaxCyte includes Casdin Partners Master Fund, L, Douglas Doerfler, John Joseph Johnston, Maher Masoud, Richard Douglas, Stanley C Erck, Thomas M Ross. Learn more on insiders at MXCT. What percentage of MaxCyte stock is owned by insiders? 3.00% of MaxCyte stock is owned by insiders. Learn more on MXCT's insider holdings. Which MaxCyte insiders have been buying company stock? The following insiders have purchased MXCT shares in the last 24 months: Maher Masoud ($489,113.29), and Richard Douglas ($345,600.00). How much insider buying is happening at MaxCyte? Insiders have purchased a total of 180,000 MXCT shares in the last 24 months for a total of $834,713.29 bought. Which MaxCyte insiders have been selling company stock? The following insiders have sold MXCT shares in the last 24 months: Douglas Doerfler ($665,110.62), John Joseph Johnston ($287,389.39), Stanley C Erck ($198,336.96), and Thomas M Ross ($261,122.94). How much insider selling is happening at MaxCyte? Insiders have sold a total of 366,999 MaxCyte shares in the last 24 months for a total of $1,704,455.09 sold. MaxCyte Key ExecutivesMr. Maher Masoud (Age 49)President, CEO & Executive Director Compensation: $650.98k2 recent tradesMr. Douglas Arthur Doerfler (Age 68)Founder Compensation: $2.34MMr. Douglas J. Swirsky CFA (Age 55)CPA, Chief Financial Officer Compensation: $607.42kMr. Jay GelfmanSenior Vice President of OperationsMr. Ronald Evan Holtz CPA (Age 66)Ph.D., Executive Vice President of Administration Compensation: $649.38kMr. David Sandoval (Age 46)Senior Vice President, General Counsel & Corporate Secretary Mr. Thomas Michael Ross (Age 63)Executive Vice President of Global Sales Mr. Jack HorganVice President of Corporate DevelopmentMs. Jill MayerSenior Vice President of Human ResourcesDr. J. Stark Thompson Ph.D. (Age 82)Consultant Compensation: $84.71k More Insider Trading Tools from MarketBeat Related Companies Arcturus Therapeutics Insider Selling MeiraGTx Insider Selling MacroGenics Insider Selling Heron Therapeutics Insider Selling AnaptysBio Insider Selling Harvard Bioscience Insider Selling NV5 Global Insider Selling LegalZoom.com Insider Selling Evolent Health Insider Selling TaskUs Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:MXCT) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MaxCyte, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MaxCyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
